Search Results
You are looking at 1 - 1 of 1 items for
- Author: Darina Tamayo x
- Refine by access: All content x
Nicola Fazio
Nicola Fazio
Division of gastrointestinal medical oncology and neuroendocrine tumors, European Institute of Oncology (IEO) IRCCS, Milan, Italy
Search for other papers by Nicola Fazio in
Google Scholar
PubMed
Search for other papers by Nicola Fazio in
Google Scholar
PubMed
Lorenzo Gervaso
Lorenzo Gervaso
Division of gastrointestinal medical oncology and neuroendocrine tumors, European Institute of Oncology (IEO) IRCCS, Milan, Italy
Molecular Medicine Program, University of Pavia, Pavia, Italy
Search for other papers by Lorenzo Gervaso in
Google Scholar
PubMed
Molecular Medicine Program, University of Pavia, Pavia, Italy
Search for other papers by Lorenzo Gervaso in
Google Scholar
PubMed
Thorvardur R Halfdanarson
Thorvardur R Halfdanarson
Division of Medical Oncology Mayo Clinic, Rochester, Minnesota, USA
Search for other papers by Thorvardur R Halfdanarson in
Google Scholar
PubMed
Search for other papers by Thorvardur R Halfdanarson in
Google Scholar
PubMed
Mohamad Sonbol
Mohamad Sonbol
Department of Hematology and Oncology, Mayo Clinic, Phoenix, Arizona, USA
Search for other papers by Mohamad Sonbol in
Google Scholar
PubMed
Search for other papers by Mohamad Sonbol in
Google Scholar
PubMed
Rachel A Eiring
Rachel A Eiring
Division of Medical Oncology Mayo Clinic, Rochester, Minnesota, USA
Search for other papers by Rachel A Eiring in
Google Scholar
PubMed
Search for other papers by Rachel A Eiring in
Google Scholar
PubMed
Sara Pusceddu
Sara Pusceddu
Division of Medical Oncology, National Cancer Institute, Milan, Italy
Search for other papers by Sara Pusceddu in
Google Scholar
PubMed
Search for other papers by Sara Pusceddu in
Google Scholar
PubMed
Natalie Prinzi
Natalie Prinzi
Division of Medical Oncology, National Cancer Institute, Milan, Italy
Search for other papers by Natalie Prinzi in
Google Scholar
PubMed
Search for other papers by Natalie Prinzi in
Google Scholar
PubMed
Benedetta Lombardi Stocchetti
Benedetta Lombardi Stocchetti
Division of Medical Oncology, National Cancer Institute, Milan, Italy
Search for other papers by Benedetta Lombardi Stocchetti in
Google Scholar
PubMed
Search for other papers by Benedetta Lombardi Stocchetti in
Google Scholar
PubMed
Simona Grozinsky-Glasberg
Simona Grozinsky-Glasberg
Neuroendocrine Tumor Unit, ENETS Center of Excellence, Department of Endocrinology and Metabolism, Hadassah Medical Center and Faculty of Medicine, The Hebrew University, Jerusalem, Israel
Search for other papers by Simona Grozinsky-Glasberg in
Google Scholar
PubMed
Search for other papers by Simona Grozinsky-Glasberg in
Google Scholar
PubMed
David J Gross
David J Gross
Neuroendocrine Tumor Unit, ENETS Center of Excellence, Department of Endocrinology and Metabolism, Hadassah Medical Center and Faculty of Medicine, The Hebrew University, Jerusalem, Israel
Search for other papers by David J Gross in
Google Scholar
PubMed
Search for other papers by David J Gross in
Google Scholar
PubMed
Thomas Walter
Thomas Walter
Medical Oncology Department, Hopital Edourad Herriot, Hospices civils de Lyon, Lyon, France
Search for other papers by Thomas Walter in
Google Scholar
PubMed
Search for other papers by Thomas Walter in
Google Scholar
PubMed
Patrick Robelin
Patrick Robelin
Medical Oncology Department, Hopital Edourad Herriot, Hospices civils de Lyon, Lyon, France
Search for other papers by Patrick Robelin in
Google Scholar
PubMed
Search for other papers by Patrick Robelin in
Google Scholar
PubMed
Catherine Lombard-Bohas
Catherine Lombard-Bohas
Medical Oncology Department, Hopital Edourad Herriot, Hospices civils de Lyon, Lyon, France
Search for other papers by Catherine Lombard-Bohas in
Google Scholar
PubMed
Search for other papers by Catherine Lombard-Bohas in
Google Scholar
PubMed
Samuele Frassoni
Samuele Frassoni
Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milan, Italy
Search for other papers by Samuele Frassoni in
Google Scholar
PubMed
Search for other papers by Samuele Frassoni in
Google Scholar
PubMed
Vincenzo Bagnardi
Vincenzo Bagnardi
Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milan, Italy
Search for other papers by Vincenzo Bagnardi in
Google Scholar
PubMed
Search for other papers by Vincenzo Bagnardi in
Google Scholar
PubMed
Lorenzo Antonuzzo
Lorenzo Antonuzzo
Clinical Oncology Unit, Careggi University Hospital, Florence, Italy
Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy
Search for other papers by Lorenzo Antonuzzo in
Google Scholar
PubMed
Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy
Search for other papers by Lorenzo Antonuzzo in
Google Scholar
PubMed
Clotilde Sparano
Clotilde Sparano
Endocrinology Unit, Department of Experimental and Clinical Biomedical Sciences ’Mario Serio’, University of Florence, Florence, Italy
Search for other papers by Clotilde Sparano in
Google Scholar
PubMed
Search for other papers by Clotilde Sparano in
Google Scholar
PubMed
Sara Massironi
Sara Massironi
Division of Gastroenterology, and Center for Autoimmune Liver Diseases, European Reference Network on Hepatological Diseases (ERN RARE-LIVER), San Gerardo Hospital, University of Milano-Bicocca School of Medicine, Monza, Italy
Search for other papers by Sara Massironi in
Google Scholar
PubMed
Search for other papers by Sara Massironi in
Google Scholar
PubMed
Fabio Gelsomino
Fabio Gelsomino
Division of Oncology. Department of Hematology and Oncology, University Hospital of Modena, Modena, Italy
Search for other papers by Fabio Gelsomino in
Google Scholar
PubMed
Search for other papers by Fabio Gelsomino in
Google Scholar
PubMed
Alberto Bongiovanni
Alberto Bongiovanni
Oncologia medica, IRCCS Istituto Romagnolo per lo Studio dei Tumori ’Dino Amadori’, IRST S.r.l., Meldola, Italy
Search for other papers by Alberto Bongiovanni in
Google Scholar
PubMed
Search for other papers by Alberto Bongiovanni in
Google Scholar
PubMed
Nicoletta Ranallo
Nicoletta Ranallo
Oncologia medica, IRCCS Istituto Romagnolo per lo Studio dei Tumori ’Dino Amadori’, IRST S.r.l., Meldola, Italy
Search for other papers by Nicoletta Ranallo in
Google Scholar
PubMed
Search for other papers by Nicoletta Ranallo in
Google Scholar
PubMed
Salvatore Tafuto
Salvatore Tafuto
Oncologia Sarcomi e Tumori rari, I.R.C.C.S. Ist. Naz. Tumori di Napoli ’G. Pascale’, Napoli, Italy
Search for other papers by Salvatore Tafuto in
Google Scholar
PubMed
Search for other papers by Salvatore Tafuto in
Google Scholar
PubMed
Maura Rossi
Maura Rossi
Oncology Unit and Centro Documentazione Osteonecrosi, Azienda Ospedaliera SS Antonio e Biagio e Cesare Arrigo, Alessandria, Italy
Search for other papers by Maura Rossi in
Google Scholar
PubMed
Search for other papers by Maura Rossi in
Google Scholar
PubMed
Mauro Cives
Mauro Cives
Department of Interdisciplinary Medicine, University of Bari ’Aldo Moro’, Bari, Italy
Search for other papers by Mauro Cives in
Google Scholar
PubMed
Search for other papers by Mauro Cives in
Google Scholar
PubMed
Ibrahim Rasul Kakil
Ibrahim Rasul Kakil
National Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar
Search for other papers by Ibrahim Rasul Kakil in
Google Scholar
PubMed
Search for other papers by Ibrahim Rasul Kakil in
Google Scholar
PubMed
Hytam Hamid
Hytam Hamid
Department of Surgery, Al-Moalem Medical City, Khartoum, Sudan
Search for other papers by Hytam Hamid in
Google Scholar
PubMed
Search for other papers by Hytam Hamid in
Google Scholar
PubMed
Alessandra Chirco
Alessandra Chirco
UO Oncologia Medica ASST Papa Giovanni XXIII, Bergamo, Italy
Search for other papers by Alessandra Chirco in
Google Scholar
PubMed
Search for other papers by Alessandra Chirco in
Google Scholar
PubMed
Michela Squadroni
Michela Squadroni
Oncologia medica, Humanitas Gavazzeni Bergamo, Bergamo, Italy
Search for other papers by Michela Squadroni in
Google Scholar
PubMed
Search for other papers by Michela Squadroni in
Google Scholar
PubMed
Anna La Salvia
Anna La Salvia
Medical Oncology Department, Hospital Universitario Doce de Octubre, Imas12, UCM, Madrid, Spain
Search for other papers by Anna La Salvia in
Google Scholar
PubMed
Search for other papers by Anna La Salvia in
Google Scholar
PubMed
Jorge Hernando
Jorge Hernando
Vall Hebron University Hospital and Vall Hebron Institute of Oncology (VHIO), Barcelona, Spain
Search for other papers by Jorge Hernando in
Google Scholar
PubMed
Search for other papers by Jorge Hernando in
Google Scholar
PubMed
Johannes Hofland
Johannes Hofland
Department of Internal Medicine, Sector Endocrinology, Rotterdam, the Netherlands
Search for other papers by Johannes Hofland in
Google Scholar
PubMed
Search for other papers by Johannes Hofland in
Google Scholar
PubMed
Anna Koumarianou
Anna Koumarianou
Hematology-Oncology Unit, Fourth Department of Internal Medicine, Attikon Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece
Search for other papers by Anna Koumarianou in
Google Scholar
PubMed
Search for other papers by Anna Koumarianou in
Google Scholar
PubMed
Sabrina Boselli
Sabrina Boselli
Data Management-Clinical Trial Office. Scientific Direction. European Institute of Oncology (IEO) IRCCS, Milan, Italy
Search for other papers by Sabrina Boselli in
Google Scholar
PubMed
Search for other papers by Sabrina Boselli in
Google Scholar
PubMed
Darina Tamayo
Darina Tamayo
Data Management-Clinical Trial Office. Scientific Direction. European Institute of Oncology (IEO) IRCCS, Milan, Italy
Search for other papers by Darina Tamayo in
Google Scholar
PubMed
Search for other papers by Darina Tamayo in
Google Scholar
PubMed
Cristina Mazzon
Cristina Mazzon
Data Management-Clinical Trial Office. Scientific Direction. European Institute of Oncology (IEO) IRCCS, Milan, Italy
Search for other papers by Cristina Mazzon in
Google Scholar
PubMed
Search for other papers by Cristina Mazzon in
Google Scholar
PubMed
Manila Rubino
Manila Rubino
Division of gastrointestinal medical oncology and neuroendocrine tumors, European Institute of Oncology (IEO) IRCCS, Milan, Italy
Search for other papers by Manila Rubino in
Google Scholar
PubMed
Search for other papers by Manila Rubino in
Google Scholar
PubMed
Francesca Spada
Francesca Spada
Division of gastrointestinal medical oncology and neuroendocrine tumors, European Institute of Oncology (IEO) IRCCS, Milan, Italy
Search for other papers by Francesca Spada in
Google Scholar
PubMed
Search for other papers by Francesca Spada in
Google Scholar
PubMed
We conducted a retrospective/prospective worldwide study on patients with neuroendocrine neoplasms (NENs) and a molecularly proven SARS-CoV-2 positivity. Preliminary results regarding 85 patients of the INTENSIVE study have been published in 2021. Now we are reporting the 2-year analysis.Here, we are reporting data from consecutive patients enrolled between 1 June 2020, and 31 May 2022. Among the 118 contacted centers, 25 were active to enroll and 19 actively recruiting at the time of data cut-off for a total of 280 patients enrolled. SARS-CoV-2 positivity occurred in 47.5% of patients in 2020, 35.1% in 2021, and 17.4% in 2022. The median age for COVID-19 diagnosis was 60 years. Well-differentiated tumors, non-functioning, metastatic stage, and gastroenteropancreatic (GEP) primary sites represented most of the NENs. COVID-19-related pneumonia occurred in 22.8% of the total, with 61.3% of them requiring hospitalization; 11 patients (3.9%) needed sub-intensive or intensive care unit therapies and 14 patients died (5%), in 11 cases (3.9%) directly related to COVID-19. Diabetes mellitus and age at COVID-19 diagnosis > 70 years were significantly associated with COVID-19 mortality, whereas thoracic primary site with COVID-19 morbidity. A significant decrease in both hospitalization and pneumonia occurred in 2022 vs 2020. In our largest series of NEN patients with COVID-19, the NEN population is similar to the general population of patients with NEN regardless of COVID-19. However, older age, non-GEP primary sites and diabetes mellitus should be carefully considered for increased COVID-19 morbidity and mortality. Relevant information could be derived by integrating our results with NENs patients included in other cancer patients with COVID-19 registries.
